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INTRODUCTION
Approximately 400 children are diagnosed with cancer in
the Netherlands every year [1]. The diagnosis of childhood
cancer has an enormous impact on the child and his family.
They are confronted with a life-threatening disease mostly
implying extensive treatment with negative side-effects and
the risk of negative long-term consequences. Considerable
literature has been devoted to the long-term adjustment of the
child [2–4]. It can be concluded that dealing with childhood
cancer is a dramatic event that could influence physical and
psychosocial functioning long time after termination of the
treatment [2,5,6]. In addition, post-traumatic stress symp-
toms appeared to be common in families of childhood cancer;
among survivors of childhood cancer, as well as among their
parents [7–10]. Nevertheless, many long-term survivors of
childhood cancer turned out to function well [11,12](see
reviews by Langeveld et al. [3] and Stam et al. [4]). This
appeared also to be true for their parents; overall, most of
them did not experience more emotional disturbances than
healthy controls [13–16]. However, if illness related
concerns were taken into account, parents of survivors of
childhood cancer seemed to experience feelings of uncer-
tainty and loneliness [17,18].
Less is known about what happens in the years imme-
diately after successful treatment. During treatment, patients
and their families may have struggled for life, living day by
day, supported intensively by the medical staff and social
support networks. After termination of treatment, concerns
about the further course of the disease as well as the child’s
education and employment can take the place of treatment-
related worries [2]. The social and emotional support also
often decrease when active treatment ends. Families have to
integrate their experiences in normal daily life and have to
face future challenges relating to issues surrounding the
diagnosis and treatment of cancer. These first years following
the end of treatment can be considered as an important phase
of adjustment to the cancer experience. A longitudinal study
was designed in order to gain insight into this process of
adjustment.
The results presented here concern the first assessment of
the longitudinal study among the childhood cancer patients
and their parents, 2 months after the termination of the cancer
treatment. We considered this moment of assessment to be
interesting because it represents the transition from active
treatment to ‘‘normal daily life.’’ The aims of the current
study are the assessment of (1) health-related quality of life
(HRQOL) 2 months after the end of treatment, using
comprehensive instruments that measure physical, cognitive,
social as well as emotional aspects of HRQOL, and (2) the
emotional adjustment of the parents 2 months after the end of
treatment of their child.
Background. Completing therapy is one of the major transitions
in care in the practice of pediatric oncology and, therefore, deserves
special consideration. The purpose of the study was to investigate
health-related quality of life (HRQOL) of pediatric patients, and
emotional reactions of their parents, shortly after the end of
successful treatment. Methods. HRQOL of 126 patients, aged 1–
15 years, on average 2 months after the end of successful treatment,
was assessed with the TNO-AZL Pre-school Quality of life
Questionnaire and the TNO-AZL Children’s Quality of life Ques-
tionnaire. Emotional adjustment of 124 mothers and 111 fathers was
assessed with the General Health Questionnaire and the Situation
Specific Emotional Reaction Questionnaire. The outcomes of the
patients and parents were compared with norm data by means of one
sample t-tests, one sample sign-tests or binomial tests. Results. All
age groups, except patients aged 8–11 years, experienced worse
HRQOL than the norm with respect to motor functioning. In
addition, pre-school patients were rated worse on sleeping, appetite,
stomach, skin, problem behavior, anxiety, and liveliness, and
patients aged 6–7 years on autonomy and cognitive functioning.
Parents reported more psychological distress than the norm.
Compared to parents whose children were 1–5 years after cancer
treatment, they suffered more from feelings of loneliness, help-
lessness, and uncertainty. Conclusions. A few months after the end of
successful cancer treatment, both patients and parents appeared to
experience worse well-being than the norm to a clinically relevant
extent. Supporting patients and parents should not stop when
treatment ends. Pediatr Blood Cancer 2006;47:312–319.
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PATIENTS AND METHODS
Procedure
The results presented here concern the first measurement
of the longitudinal VOLG-study (Vragenlijsten kinderOnco-
logie Latere Gevolgen), a Dutch study on the late
psychosocial consequences of cancer in childhood. It started
in 2000 and will end in 2006. The respondents of the VOLG-
study were recruited from the The Emma Children’s
Hospital/Academic Medical Center in Amsterdam (from
March 2000 until the end of 2002) and the Radboud
University Nijmegen Medical Center (from June 2002 until
the end of 2002). Inclusion criteria were: (1) age 1–18 years,
(2) complete first remission, (3) end of successful treatment
at most 2 months before, and (4) being able to complete
Dutch questionnaires.
Parents of children with cancer, and children with cancer
aged 8 years or older were informed about the VOLG-study
by letter. After informed consent was obtained, the parents
were telephoned and an appointment was made for comple-
tion of questionnaires anonymously in the hospital or at
home. The children and parents were instructed to complete
the questionnaires independently. The assistance of the
researcher was restricted to reading questions out loud and to
explaining the meaning of difficult words. Some parents and
some patients aged 15 years or older filled in the
questionnaires without the assistance of the researcher, at
home. The respondents were asked to complete the
questionnaires, yearly, four to six times, depending on the
year of inclusion. The results of the first assessment were
used in this study. The self reports of the patients aged 16
years or older were not included in this study because of the
small number of eight patients in this age group. A unique
patient number made it possible to gather medical informa-
tion, from the respondents as well as from the non-
respondents. The Medical Ethic Committee of the Academic
Medical Center in Amsterdam and the Radboud University
Nijmegen Medical Center has approved the study protocol.
Measures
Health-related quality of life. HRQOL of the child-
hood cancer patients was assessed with the TNO-AZL Pre-
school Quality of Life questionnaire for children aged 1–
5 years (TAPQOL) [19,20], and with the TNO-AZL Child-
ren’s Quality of Life questionnaire; Parent Form for children
aged 6–11 years (TACQOL-PF) [21] and Child Form for
children aged 8–15 years (TACQOL-CF), [22,23]. These
questionnaires are generic Dutch instruments that measure
health status problems weighted by the impact of the health
status problems on well-being. It offers the respondent the
possibility of differentiating between their functioning and
the way they feel about it. Most of the items consist of two
questions linked to one another. On the first one, the
respondent can rate whether or not a specific problem
occurred in the past few weeks. The second one is about the
possible negative emotional responses to the problems. The
respondent can indicate how he (or his child) felt about this
problem on a four point Likert scale: fine, not so good, quite
bad, bad. The items are clustered into multi-item scales with
higher scores indicating better quality of life. Norm data from
the general Dutch population were available. The instru-
ments measure HRQOL on group level in a reliable and valid
way [19–24].
The TAPQOL assesses the child’s functioning on 12
domains: sleeping, appetite, lungs, stomach, skin, motor
functioning, social functioning, problem behavior, commu-
nication, anxiety, positive mood, liveliness. The raw scales
scores of the TAPQOL are converted to a 0–100 scale. The
Cronbach alphas in our study population were moderate to
good. Norm data were collected via a sample from the
general population of children visiting well-baby clinics in
the Netherlands in 1997. Periodically, almost all children
aged 0–5 years in the Netherlands visit well-baby clinics
[19].
The TACQOL for children aged 6–11 years (PF) or aged
8–11 years (CF), assesses functioning on seven domains:
physical complaints, motor functioning, autonomy, cognitive
functioning, social functioning (in relation to parents and
peers), positive emotions, and negative emotions. The
TACQOL for adolescents, aged 12–15 years, assesses
functioning on six domains: physical complaints, motor
functioning, cognitive functioning, social functioning (in
relation to peers), positive emotions and negative emotions.
The Cronbach alphas, in our study population, were
moderate to good. Norm data were collected via the Centers
for Preventive Youth Health Care all over The Netherlands,
via stratified random sampling [21–23,25].
Medical data. Medical data were obtained from the
medical record of the ill child. Prognosis was based on
the oncologist’s rating of the child’s survival chances at
diagnosis, that is, <25%, 25–75%, >75%.
Parental distress. Parental distress was measured with
the General Health Questionnaire-30 (GHQ-30) [26,27], a
30-item self-report measure. The raw total scale score can be
used as an overall index of psychological distress, ranging
from 0 to 30 with higher scores indicating more distress.
According to Goldberg et al. [26], scores 5 indicate
clinically elevated levels of psychological distress. The
validity of the 30-item version is well documented and
internal reliability is highly satisfactory [26]. Cronbach alpha
in the current study is high (a¼ 0.92).
Parental situation-specific emotional reactions. Par-
ental situation-specific emotional reactions were assessed
with the Situation Specific Emotional Reaction Questionnaire
(SSERQ). This is a Dutch questionnaire that consists of 30
items, divided in four subscales, which describe feelings that
can be considered situation-specific for parents of children
with cancer. It concerns feeling of (1) loneliness, 11 items, for
example, ‘‘I have the feeling that nobody understands what I
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am going through,’’ (2) helplessness, 7 items, for example, ‘‘I
feel helpless that I can’t do anything about the situation,’’ (3)
uncertainty, 6 items, for example, ‘‘I am uncertain about the
course of the disease,’’ and (4) positive feelings, 6 items, for
example, ‘‘I have the feeling that I can enjoy small things
more tremendously.’’ Parents were asked to indicate whether
they experienced an emotional reaction on a 4-point scale:
never, sometimes, often, almost all the time. The higher the
scores the more often parents experienced the emotional
reactions. The validity and reliability turned out to be
satisfactory in former studies [28]. The Cronbach alphas in
the current study were also satisfactory, ranging from
a¼ 0.71 to a¼ 0.85.
Statistical Analyses
The Statistical Package for Social Sciences (SPSS),
Windows version 11.5, was used for all analyses. Before
conducting the final analyses several preparation analyses
were conducted. First, scales were constructed and missing
data imputed on the basis of the guidelines of the
questionnaires used. Second, the reliability of these scales
was calculated. Third, descriptive statistics were used to
describe the demographic and medical characteristics of the
participants. Finally, binomial tests were performed in order
to test whether the distribution by gender in the several
patient groups (1–5, 6–7, 8–11, and 12–15 years) differed
from that in the age-matched norm groups.
HRQOL of the childhood cancer patients. One sample
t-tests, or, if the sample size was smaller than 20, non-
parametric equivalents (one sample sign-test or binomial
test), were performed to test whether the mean score, the
median, or the binomial distribution of the several HRQOL-
scales scores of the childhood cancer patients differed from
the norm data available. A significance level of P< 0.005
was used in order to compensate for multiple testing. Effect
sizes (d) were calculated by dividing the difference in mean
score between the childhood cancer patients and the norm
group by the standard deviation of the scores in the norm
group. According to Cohen, effect sizes of up to 0.2 were
considered to be small, effect sizes of about 0.5 to be
moderate, and effect sizes of about 0.8 to be large [29].
Patients’ self-reports were used for analysis unless
the self-report was not available due to the young age of
the patient. Separate analyses were conducted for (1) patients
aged 1–5 years, using the TAPQOL, (2) patients aged 6–
7 years, using the TACQOL-PF, (3) patients aged 8–11 years,
using the TACQOL-CF for children, and (4) patients aged
12–15 years, using the TACQOL-CF for adolescents.
Separate analyses by gender were performed in the age
group 8–11 years because the distribution of gender in this
patient group differed from that in the norm group. This was
not the case in the other age groups.
Parental emotional reactions. Parental psychological
distress was compared with the Dutch norm by conducting
one sample t-tests on the mean total GHQ-score, and
binomial testing on the percentage ‘‘clinically elevated
levels of psychological distress,’’ that is, GHQ-scores 5.
Analyses were performed for mothers and fathers separately.
Effect sizes could not be calculated because the standard
deviations of the mean scores among the norm group were
not available. The mean items scores on the subscales of the
SSERQ, computed for mother and fathers separately, were
compared to the mean items scores of mothers and fathers of
children who were off cancer treatment for 1–5 years [28].
One-sample t-tests were conducted and effect sizes were
calculated.
RESULTS
Participants
A total of 164 consecutive childhood cancer patients who
completed treatment successfully at most 2 months before,
and their parents, were approached for the longitudinal part
of the VOLG-study; 150 patients from The Emma Children’s
Hospital AMC and 14 patients from the Radboud University
Nijmegen Medical Center. The response rate was 81.7 per
cent (N¼ 134). Of the 30 families who did not participate, 9
did not want to be confronted with cancer any longer, 8 did
not return the informed consent form, and 5 did not return the
questionnaires. Other reasons of refusal were: recurrence of
the disease (N¼ 3), multiple family problems (N¼ 3), not
being able to complete Dutch questionnaires (N¼ 2). No
significant differences were found (P< 0.1 at t-tests or w2-
tests) between the participants and non-participants with
respect to age, gender, and several medical variables
(Table I).
The final study sample of the VOLG-study consisted of
134 patients, 124 mothers, and 111 fathers. Their socio-
demographic and medical characteristics were presented in
Tables I and II. A total of 60 patients were old enough to
complete questionnaires themselves. The self reports of eight
patients aged 16 years or older were not included in this study.
The 52 patients aged 8–15 years filled in the TACQOL-CF;
25 patients aged 8–11 years, and 27 patients aged 12–
15 years. The researchers assigned the parent-form of the
HRQOL-questionnaires at random to the father or the mother
of the patients aged 1–7 years. The TAPQOL for children
aged 1–5 years was completed by 35 mothers and 19 fathers.
A total of nine mothers and nine fathers of children aged 6–
7 years filled in the TACQOL-PF. All parents filled in the
questionnaires about their own emotional well-being.
Health-Related Quality of Life of Childhood
Cancer Patients Off Treatment
Patients aged 1–5 years. The HRQOL of the pre-school
patients appeared to be significantly worse (P< 0.005) than
the HRQOL of age-matched children from the general Dutch
population, on eight out of the twelve scales of the TAPQOL:
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sleeping T(1,53)¼4.4, appetite T(1,52)¼4.2, stomach
T(1,53)¼6.2, skin T(1,53)¼3.0, motor functioning
T(1,50)¼6.1, problem behavior T(1,53)¼3.4, anxiety
T(1,52)¼6.5, liveliness T(1,52)¼3.6. These differ-
ences were moderate to large: effect sizes (d) ranged from
d¼ 0.4 for skin to d¼ 3.7 for motor functioning. No
significant differences were found on the following scales:
lungs, social functioning, communication, positive mood
(Table III).
Patients aged 6–7 years. According to the results of
non-parametric testing, the parent-reported HRQOL
of the patients aged 6–7 years was significantly worse
(P< 0.005) than that of age-matched children from the
general Dutch population with respect to motor functioning,
autonomy, and cognitive functioning. The differences were
large: effect size (d)¼ 3.2 for motor functioning, d¼ 2.7 for
autonomy, and d¼ 1.0 for cognitive functioning. The
patients did not differ from the general population on the
other TACQOL-PF scales: physical complaints, social
functioning, positive emotions, and negative emotions
(Table IV).
Patients aged 8–11 years. On the basis of the
TACQOL self-reports, the patients aged 8–11 years seemed
not to differ from the general Dutch population of 8–11 aged
children, at a significance level of P< 0.005 (Table V).
However, the cancer patients tended to score worse than the
general population on motor functioning (T(1,23)¼ 2.3;
P¼ 0.03) and autonomy (T(1,22)¼ 2.2; P¼ 0.04). The
TABLE I. Socio-Demographic and Medical Characteristics of the Participant and Non-Participant Patients
Participants Non-participants
M SD Range N M SD Range N
Age at study (years) 8.3 4.6 1.1–18.2 134 8.4 4.9 1.7–17.7 30
Age at first diagnosis (years) 7.1 4.7 0.3–17.2 134 7.8 5.2 0.6–17.2 30
Time since first diagnosis (months) 13.6 8.3 2.0–29.7 134
Time since end of last treatment (months) 2.2 1.0 0.1–5.7 134
Duration of treatment (months) 11.4 8.3 0.6–26.0 134 12.5 9.5 0.5–26.1 29
Days of admission in Emma Children’s hospital 44.9 30.2 2–141 120 45.7 30.6 5–127 27
% N % N
Age categories
1–5 years 40.3 54 40.0 12
6–11 years 33.6 45 26.7 8
12–15 years 20.1 27 26.7 8
16–18 yearsa 6.0 8 6.7 2
Gender
Female 43.3 58 38.7 12
Native country
The Netherlands 96.2 128
Diagnosis
Leukemia/lymphoma 47.8 64 53.3 16
Solid tumor 47.8 64 40.0 12
Brain tumor 4.5 6 6.7 2
Treatmentb
Chemotherapy 95.5 128 89.7 26
Radiotherapy 18.7 25 17.2 5
Surgery 47.0 63 44.8 13
Autologous bone marrow transplantation 2.2 3 3.4 1
Other 2.2 3 3.4 1
Prognosis
<25% 5.2 7 6.9 2
25–75% 41.0 55 31.0 9
>75% 53.7 72 62.1 18
Visible consequences of the diseaseb
None 68.8 86
Amputation 4.8 6
Moon-faced 6.5 8
Bald 37.1 46
Scars 21.8 27
Wheel chair 4.0 5
Other 27.2 34
aThe self reports of this patients were not included in the present study.
bMore than one answer is possible per patient.
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effect sizes were moderate to large: d¼ 0.7 and d¼ 0.9 for
motor functioning and autonomy, respectively. The non-
parametric analysis by gender revealed no significant
differences between the cancer patients and the general
population, although the cancer patients scored worse on all
scales of the TACQOL-CF.
Patients aged 12–15 years. The cancer patients aged
12–15 years appeared to score significantly worse than the
general population on motor functioning: T(1,24)¼1.0,
P< 0.005, which is considered a large effect (d¼ 1.5). No
significant differences were found on the other scales, and the
corresponding effect sizes were small (Table V).
Emotional Reactions of Parents of Childhood
Cancer Patients Off Treatment
Parental psychological distress. Mothers as well as
fathers reported significantly more psychological distress
(P< 0.001) than the general Dutch population: T(114)¼
10.5 and T(107)¼ 7.3 for mothers and fathers, respectively.
The mean level of distress of the mothers (M¼ 10.1) as well
as that of the fathers (M¼ 8.2) was in the clinical range, that
is, GHQ-total score5. Moreover, the percentage of mothers
and fathers who reported a clinically elevated level of
psychological distress was significantly higher (P< 0.001)
TABLE II. Socio-Demographic Characteristics of the Participating Parents
M SD Range N
Age mother (years) 37.8 5.0 26.0–50.0 124
Age father (years) 39.8 5.2 29.0–54.0 108
% N
Family
Father and mother, and child(ren) 94.0 125
Father or mother, and child(ren) 4.5 6
Other 1.5 2
Eductional levela father
Low 21.8 24
Middle 34.6 38
High 43.6 48
Educational levela mother
Low 43.1 53
Middle 30.8 38
High 26.0 32
aHighest level completed: Low: primary education, technical, and vocational training, Lower and middle
general secondary education; Middle: middle vocational education, higher general secondary education,
pre-university education; High: higher vocational education, university.
TABLE III. Mean (M) and Standard Deviation (SD) of the Scoresa
on the TAPQOL-PF, Childhood Cancer Patients Aged 1–5 Years
Versus the Normb
Parent report
Cancer patients
(1–5 years) Norm Effect size
M SD N M d
Sleeping 67.9* 24.1 54 82.3 0.8
Appetite 74.7* 17.1 53 84.6 0.8
Lungs 94.0 14.6 53 93.6 0.0
Stomach 72.4* 23.2 54 91.9 1.4
Skin 87.5* 10.5 54 91.8 0.4
Motor functioning 81.9* 19.5 51 98.5 3.7
Social functioning 84.7 24.0 50 91.3 0.4
Problem behavior 55.6* 26.1 54 67.7 0.8
Communication 92.9 14.3 50 91.7 0.1
Anxiety 55.0* 26.1 53 78.3 1.3
Positive mood 92.1 17.2 53 98.7 1.0
Liveliness 87.4* 21.2 53 98.0 1.3
*P< 0.005 at one sample t-test: cancer patients versus norm.
aScores range from 0 to 100, higher scores representing better HRQOL.
bGeneral Dutch population of children aged 1–5 years [19].
TABLE IV. Mean (M)a and Standard Deviation (SD) of the Raw
Scoresb on the TACQOL-PF, Childhood Cancer Patients Aged 6–7
Years Versus the Normc
Parent report
Cancer patients
(6–7 years) Norm
Effect
size
M SD N M d
Physical complaints 25.2 (78.8) 4.9 18 27.5 0.6
Motor functioning 24.0* (75.0) 6.6 18 31.0 3.2
Autonomy 25.6* (80.1) 6.2 18 31.0 2.7
Cognitive functioning 26.0* (81.3) 5.7 15 29.6 1.0
Social functioning 28.7 (89.6) 2.8 18 30.2 0.7
Positive emotions 14.4 (89.9) 2.4 18 15.0 0.3
Negative emotions 11.0 (68.8) 2.5 18 11.4 0.2
*P< 0.005 at non-parametric testing (sign-test or binomial test): cancer
patients versus norm.
aHigher scores represent better HRQOL: range 0–32 for physical,
motor, cognitive, social, autonomy; range 0–16 for positive and
negative emotions.
bTransformed scores (0–100) are put between brackets.
cGeneral Dutch population of children aged 6–7 years [25].
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than the percentage in the general population. Almost three-
fourths of the mothers (72%) fell in the clinical range versus
24% of the female Dutch population. Among the fathers, we
found 60% to be in the clinical range versus 22% of the male
Dutch population (Table VI).
Parental situation-specific emotional reactions. The
results in Table VII indicated that a considerable part of the
mothers as well as of the fathers often experience feelings of
helplessness, on average 2 months after the end of successful
treatment of their child. However, they also often experience
positive feelings. Feelings of uncertainty appeared to be
experienced sometimes, while feelings of loneliness were
reported less frequently.
Compared to parents whose children were 1–5 years after
cancer treatment [28], the parents in our study turned out to
suffer significantly more often from feelings of loneliness,
helplessness, and uncertainty, mothers (T(120)¼ 2.1,
T(121)¼ 3.1, T(121)¼ 6.7) as well as fathers (T(108)¼
3.0, T(108)¼ 8.5, T(108)¼ 6.7). Moreover, the mothers
reported less positive feelings on average 2 months after
termination of treatment than the mothers a few years after
that: T(120)¼3.5.
DISCUSSION
This study focuses on well-being of children and parents
at the transition from active treatment to normal daily life. As
far as we know, multidimensional HRQOL of pre-school
patients of childhood cancer, shortly after termination of
successful treatment, has never been assessed before. The
patients with childhood cancer appeared to experience worse
HRQOL in the physical domain, namely motor functioning.
A considerable part of the patients in almost all age groups
reported difficulty with activities such as walking, running,
and endurance. The youngest patients, aged 1–5 years, were
also rated worse HRQOL on other physical scales than motor
functioning: sleeping, appetite, lungs, stomach and skin.
These physical aspects were measured more globally among
the older patients very likely because the TACQOL take the
complaints together in one scale. The older patients seemed
not to differ from the norm on this scale of physical
complaints.
Among the older children, very few psychosocial
differences were found between patients and the normal
control group. Patients appeared to function well emotionally
TABLE V. Mean (M)a and Standard Deviation (SD) of the Raw Scoresb on the TACQOL-CF, Childhood Cancer Patients Aged 8–
11 Years Versus the Normc, 12–15 Years Versus the Normd
Child report
Cancer patients
(8–11 years) Norm Effect size
Cancer patients
(12–15 years) Norm Effect size
M SD N M d M SD N M d
Physical complaints 26.4 (82.6) 5.3 24 24.9 0.3 22.7 (71.0) 4.8 25 23.7 0.2
Motor functioning 27.7* (86.5) 4.8 24 29.8 0.7 25.0** (78.3) 5.4 25 29.8 1.5
Autonomy 29.5* (92.1) 3.7 23 31.2 0.9 — — — — —
Cognitive functioning 28.5 (89.1) 3.2 23 28.4 0.0 28.6 (89.3) 3.3 26 27.6 0.2
Social functioning 29.8 (93.0) 3.5 24 29.7 0.0 30.8 (96.4) 2.6 26 31.1 0.1
Positive emotions 12.5 (78.3) 3.1 24 13.5 0.4 12.9 (81.2) 3.6 26 13.0 0.0
Negative emotions 11.3 (70.3) 2.6 24 11.6 0.1 11.2 (70.2) 2.9 26 11.6 0.2
*P< 0.05 at one sample t-test: cancer patients versus norm.
**P< 0.005 at one sample t-test: cancer patients versus norm.
aHigher scores represent better HRQOL: range 0–32 for physical, motor, cognitive, social, autonomy; range 0–16 for positive and negative
emotions.
bTransformed scores (0–100) are put between brackets.
cGeneral Dutch population of children aged 8–11 years [25].
dGeneral Dutch population of children aged 12–15 years [23].
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TABLE VI. Psychological Distress in Parents of Childhood Cancer Patients Versus the Norma:
Mean (M) and Standard Deviation (SD) of the GHQ-30 Total Scores, and Percentage Clinically
Elevated Levels of Psychological Distress
GHQ-total scoreb GHQ-total score 5c
M SD Norm (M) % Norm (%)
Mothers (N¼ 121) 10.1* 7.5 3.0 72* 24
Fathers (N¼ 108) 8.2* 7.2 3.1 60* 22
*P< 0.001 at one sample t-test or binomial test: parents versus norm; aGeneral Dutch population [27];
bScore range 0–30; higher scores indicate higher levels of psychological distress; cScores 5 indicate a
clinically elevated level.
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in contrast to their parents who reported high levels of distress.
It is imaginable that the pediatric patients look less into the
future than their parents, whose treatment-related worries will
be replaced by the uncertainty about the future course of the
disease and concerns about their child’s education and
employment [2]. Another explanation could be that older
pediatric patients would be able to understand what has
happened. This could lead to feelings of happiness to have
survived the disease and treatment. These positive feelings
could result in under-reporting of problems and in improving
of HRQOL. This phenomenon, already described among
adults, is called ‘‘response shift.’’ It means that the experience
with cancer changes the internal standards of patients,
resulting in changes in the meaning of their self-evaluation
and hence in a possibly different experience of problems [30].
Data about pre-cancer perceptions are needed to assess
response shift.
It is reasonable to question whether patients really
functioned psychosocially as well as the norm group or
whether that there were methodological explanations.
Perhaps more differences between the patients and the norm
group would have been observed if an instrument could have
been used that assesses pediatric social and emotional
HRQOL in a more sensitive or cancer specific way than the
TAPQOL and the TACQOL do. However, HRQOL-ques-
tionnaires translated and normed for young Dutch children,
other than the TAPQOL and the TACQOL, were not available
at the start of the VOLG-study. Unfortunately, the reliability
of the social functioning scale of the TACQOL was moderate.
This is a very interesting domain in our opinion, because
recent research revealed that the social development of young
adult long-term survivors of childhood cancer was hampered
[31].
Finally, the ‘‘proxy problem’’ should be taken into
account, because the HRQOL in the younger patients was
assessed by their parents while the HRQOL of the patients
aged 8–15 years was assessed by self-report. Previous
research on the correlation between the parent-reported and
the child-reported HRQOL showed that, on average, children
reported significantly lower HRQOL than their parents on
five out of the seven scales of the TACQOL including the
positive emotions scale [32]. The comparison of the parent
report and the child report in the current study revealed no
systematic difference (internal report). Based on those data,
we believe that there is no indication of a serious ‘‘proxy
problem’’ in our study.
The parents experienced more psychological distress than
the general Dutch population, and they appeared to suffer
from feelings of loneliness, helplessness, and uncertainty.
This is not surprising given the enormous transition from
active treatment to the ‘‘coming off treatment’’ period. The
parents have to get used to live with the uncertainty about
recurrence of the disease and possible long-term side-effects.
Many parents report that they feel uncertain without the
protection of the medical treatment and support from the
hospital. However, the experience of cancer is not necessarily
in negative direction. We found that the parents often
experience positive feelings, such as ‘‘I have the feeling that I
can appreciate things more.’’ The results of research by
Greenberg and Meadows [17] were in the same direction,
which showed negative parental comments as well as positive
outcomes including the acquisition of new values and
attitudes, improved marital adjustment, and social support.
There are some limitations in the present study that should
be mentioned. First, the conclusions are based on relatively
small subgroups of patients, because different age groups
need different questionnaires. Second, the HRQOL ques-
tionnaires used had some limitations, though the TAPQOL
and TACQOL are acceptable and the best available at the start
of the study. Third, it cannot be concluded definitely that the
worse HRQOL of the patients was due to cancer or having
any chronic disease, because of the lack of data about pre-
cancer functioning.
In spite of the limitations of the study, we can conclude
that a few months after the end of successful cancer
treatment, both patients and parents experienced worse
well-being than the general Dutch population to a clinically
relevant extent. The effect sizes found on the HRQOL of the
young children with cancer in comparison with the norm
groups were large according to Cohen [29].
The results emphasize that supporting patients and parents
should not stop when treatment ends. Completing therapy is
TABLE VII. Situation-Specific Emotional Reactions of Parents of Childhood Cancer Patients on Average 2 Months After Termination of
Successful Treatment, versus Parents of Childhood Cancer Patients 1–5 Years After Termination of Successful Treatment: Mean Items
Scoreb on the SSERQ
Mothers Fathers
M (SD) N Ma Effect size (d) M (SD) N Ma Effect size (d)
Loneliness 1.47 (0.38)* 120 1.40 0.2 1.33 (0.35)** 109 1.23 0.4
Helplessness 2.30 (0.56)** 121 2.16 0.2 2.27 (0.49)*** 109 1.87 0.6
Uncertainty 2.03 (0.53)*** 121 1.72 0.7 1.88 (0.47)*** 109 1.58 0.8
Positive feelings 2.54 (0.52)*** 120 2.71 0.4 2.40 (0.50) 109 2.38 0.0
*P< 0.05 at one sample t-test; **P< 0.01 at one sample t-test; ***P< 0.001 at one sample t-test; aParents of childhood cancer patients 1–5 years
after termination of succesful treatment [28]; bItem scores: 1¼ never; 2¼ sometimes; 3¼ often; 4¼ almost all the time.
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one of the major transitions in care in the practice of pediatric
oncology and, therefore, deserves special consideration [33].
It is of importance to identify patients and parents at risk for
adjustment problems. This called for longitudinal research
directed at the predictors of patient’s and parental adjustment
in order to enable health care providers to trace and support
patients and parents at risk.
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